Reviewed by Emily Henderson, B.Sc.Oct 28 2020 Patients participating in The Leukemia & Lymphoma Society’s (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published today in the prestigious Nature Medicine journal. The Beat AML trial
Drugs
In Preferred Pharmacy Networks Dominate in 2021 Medicare Part D Plans, I highlighted how those networks will again rule next year’s Part D prescription drug plans (PDP). Today, I examine the largest retail chains’ participation in the 27 major 2021 Part D preferred networks that the nine largest plan sponsors will offer. As you will
BOSTON–(BUSINESS WIRE)–Oct. 12, 2020– Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the U.S. Food and Drug Administration (FDA) has approved Ultomiris (ravulizumab-cwvz) 100 mg/mL formulation for the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH) and for atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy for adult and pediatric (one month of age and
PLYMOUTH MEETING, PA and CHICAGO, IL, October 13, 2020 — Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, today announced the U.S. Food and Drug Administration (FDA) has approved Wakix (pitolisant) for the treatment
October 27, 2020 — Today, the U.S. Food and Drug Administration approved a lotion to treat head lice for nonprescription, or over-the-counter (OTC), use through a process called a prescription (Rx)-to-OTC switch. The FDA initially approved Sklice (ivermectin) lotion, 0.5% for the treatment of head lice infestation in patients 6 months of age and older
Unapproved New Animal Drug Products Related Links: CONCLUSION: Prevalence of antibiotic use was high not only versus other hospitals in the region but globally including Africa, coupled with significant evidence of sub-optimal prescribing. Swift action is needed to improve future prescribing to reduce AMR. One or two areas should initially be targeted for quality improvement
CGMP/Finished Pharmaceuticals/Adulterated Related Links: CONCLUSION: Prevalence of antibiotic use was high not only versus other hospitals in the region but globally including Africa, coupled with significant evidence of sub-optimal prescribing. Swift action is needed to improve future prescribing to reduce AMR. One or two areas should initially be targeted for quality improvement including development of
Unapproved Chloroquine Phosphate Product Related Links: CONCLUSION: Prevalence of antibiotic use was high not only versus other hospitals in the region but globally including Africa, coupled with significant evidence of sub-optimal prescribing. Swift action is needed to improve future prescribing to reduce AMR. One or two areas should initially be targeted for quality improvement including
IHME researchers predict the potential number of lives saved from COVID-19 this winter based on different percentages of Americans following mask and social distancing recommendations.Medscape Medical News Related Links: Publication date: Available online 10 October 2020Source: American Journal of Kidney DiseasesAuthor(s): Shreeram Akilesh, Cynthia C. Nast, Michifumi Yamashita, Kammi Henriksen, Vivek Charu, Megan L. Troxell,
Stephen Hahn, MD, Commissioner of Food and Drugs, Remarks to the Intergovernmental Working Meeting on Drug Compounding, 10/27/2020 Related Links: CONCLUSION: Prevalence of antibiotic use was high not only versus other hospitals in the region but globally including Africa, coupled with significant evidence of sub-optimal prescribing. Swift action is needed to improve future prescribing to
“I think when we’re comparing these two drugs overall, we have a clear benefit/risk, and we need to take both of these potential toxicities seriously,” said a pharmacology researcher at ID Week2020.Medscape Medical News Related Links: CONCLUSION: Prevalence of antibiotic use was high not only versus other hospitals in the region but globally including Africa,
Are antibiotic stewardship programs resilient enough to withstand pandemic-size challenges?Medscape Medical News Related Links: CONCLUSIONS: This single practice study showed total patient contact was similar over both sample periods, but most contact in 2020 was virtual. Further longitudinal multi-practice studies to confirm these findings and describe future consultation patterns are needed to inform general practice
FDA collaborates with state officials in a variety of ways, including by sharing information about compounders who engage in poor practices that could put patients at risk, sharing information about complaints and adverse events, and sharing findings from inspections. Related Links: CONCLUSION: Prevalence of antibiotic use was high not only versus other hospitals in the
VEKLURY is for use in adult and pediatric patients 12 years and older weighing at least 40 kg (88 lbs) for the treatment of coronavirus disease 2019 (COVID-19) requiring hospitalization. Related Links: Former New Jersey Gov. Chris Christie says he has been discharged from a New Jersey hospital after a week there following his announcement
Drug Supply Chain Security Act pilot project program and enhanced drug distribution security Related Links: CONCLUSION: Prevalence of antibiotic use was high not only versus other hospitals in the region but globally including Africa, coupled with significant evidence of sub-optimal prescribing. Swift action is needed to improve future prescribing to reduce AMR. One or two
Summary Company Announcement Date: October 24, 2020 FDA Publish Date: October 27, 2020 Product Type: Food & Beverages Reason for Announcement: Recall Reason Description Undeclared milk, eggs, and fish Company Name: Incredible Fish, Inc. Brand Name: Brand Name(s) Incredible Stone Crab Product Description: Product Description Incredible Stone Crab Mustard Sauce Company Announcement Incredible Fish, Inc.
French drugmaker Sanofi SA and Britain’s GlaxoSmithKline plan to make 200 million doses of their Covid-19 vaccine candidate available to the vaccine allocation plan co-led by GAVI and the World Health Organization. The companies said on Wednesday they have signed a statement of intent with vaccine alliance GAVI, which is coordinating the global plan known
Bengaluru: The state government, which has been holding preliminary discussions with Covid-19vaccine manufacturers on procurement and distribution, is yet to take a call on the most contentious issue of whether it is going to provide it free of cost to citizens or charge for it. “It is too premature to say if the government will